Virtu Financial Cut Hologic (HOLX) Stake By $424,326; Last Week Chicago Bridge & Iron Company N.V. (CBI) Analysts

April 17, 2018 - By Hazel Jackson

Hologic, Inc. (NASDAQ:HOLX) Logo

Among 17 analysts covering Chicago Bridge & Iron Company (NYSE:CBI), 6 have Buy rating, 1 Sell and 10 Hold. Therefore 35% are positive. Chicago Bridge & Iron Company had 51 analyst reports since August 14, 2015 according to SRatingsIntel. The rating was maintained by JP Morgan with “Overweight” on Thursday, April 21. The stock of Chicago Bridge & Iron Company N.V. (NYSE:CBI) has “Buy” rating given on Friday, August 21 by Zacks. As per Tuesday, December 15, the company rating was upgraded by Robert W. Baird. KeyBanc Capital Markets maintained Chicago Bridge & Iron Company N.V. (NYSE:CBI) on Tuesday, September 19 with “Hold” rating. The firm has “Hold” rating by KeyBanc Capital Markets given on Tuesday, October 31. The rating was maintained by Macquarie Research on Wednesday, June 21 with “Sell”. The rating was maintained by Robert W. Baird on Tuesday, October 31 with “Neutral”. The stock of Chicago Bridge & Iron Company N.V. (NYSE:CBI) earned “Outperform” rating by Credit Suisse on Wednesday, October 28. On Wednesday, September 2 the stock rating was upgraded by Zacks to “Buy”. The firm earned “Buy” rating on Wednesday, December 7 by Argus Research. See Chicago Bridge & Iron Company N.V. (NYSE:CBI) latest ratings:

09/04/2018 Broker: Robert W. Baird Rating: Hold New Target: $16.0000 Maintain
24/01/2018 Broker: Robert W. Baird Rating: Hold New Target: $22.0 Maintain
03/01/2018 Broker: Robert W. Baird Rating: Hold New Target: $17.0 Maintain
19/12/2017 Broker: Macquarie Research Rating: Hold Upgrade
19/12/2017 Broker: DA Davidson Old Rating: Buy New Rating: Neutral Downgrade
03/11/2017 Broker: Credit Suisse Rating: Neutral Old Target: $13 New Target: $15 Maintain
01/11/2017 Broker: UBS Rating: Neutral Old Target: $13 New Target: $17 Maintain
31/10/2017 Broker: KeyBanc Capital Markets Rating: Hold Maintain
31/10/2017 Broker: Jefferies Rating: Hold New Target: $14.5 Maintain
31/10/2017 Broker: Robert W. Baird Rating: Neutral Old Target: $10 New Target: $11 Maintain

Virtu Financial Llc decreased Hologic Inc (HOLX) stake by 61.63% reported in 2017Q4 SEC filing. Virtu Financial Llc sold 10,103 shares as Hologic Inc (HOLX)’s stock declined 13.23%. The Virtu Financial Llc holds 6,289 shares with $269,000 value, down from 16,392 last quarter. Hologic Inc now has $10.43 billion valuation. The stock increased 0.11% or $0.04 during the last trading session, reaching $37.73. About 74,543 shares traded. Hologic, Inc. (NASDAQ:HOLX) has declined 11.91% since April 17, 2017 and is downtrending. It has underperformed by 23.46% the S&P500.

Investors sentiment decreased to 0.58 in Q4 2017. Its down 0.14, from 0.72 in 2017Q3. It dropped, as 54 investors sold Chicago Bridge & Iron Company N.V. shares while 83 reduced holdings. 30 funds opened positions while 50 raised stakes. 59.08 million shares or 10.73% less from 66.18 million shares in 2017Q3 were reported. First Personal has 3,000 shares. Benjamin F Edwards & invested 0.01% of its portfolio in Chicago Bridge & Iron Company N.V. (NYSE:CBI). The New York-based Boothbay Fund Mgmt Lc has invested 0.03% in Chicago Bridge & Iron Company N.V. (NYSE:CBI). Alberta – Canada-based Her Majesty The Queen In Right Of The Province Of Alberta As Represented By Alberta Management Corp has invested 0.01% in Chicago Bridge & Iron Company N.V. (NYSE:CBI). The California-based Tarbox Family Office Incorporated has invested 0.02% in Chicago Bridge & Iron Company N.V. (NYSE:CBI). Cambridge Inv Rech Advsrs stated it has 18,382 shares. Canyon Advsr Ltd Liability Co invested in 0.02% or 100,000 shares. Bankshares Of America De owns 583,917 shares for 0% of their portfolio. Sg Americas Securities Limited Liability Co holds 0.01% or 61,206 shares. Northern Trust reported 1.16M shares or 0% of all its holdings. Voya Inv Limited Co holds 0% or 45,368 shares in its portfolio. Oakworth Inc owns 450 shares or 0% of their US portfolio. Snow Capital Mngmt Limited Partnership holds 90,879 shares. Vanguard Grp Inc owns 8.53M shares for 0.01% of their portfolio. Valley Advisers holds 0% of its portfolio in Chicago Bridge & Iron Company N.V. (NYSE:CBI) for 400 shares.

Since October 20, 2017, it had 0 insider buys, and 2 selling transactions for $242,700 activity. $122,175 worth of Chicago Bridge & Iron Company N.V. (NYSE:CBI) was sold by McCarthy Daniel M. on Friday, October 20.

Chicago Bridge & Iron Company N.V. provides conceptual design, technology, engineering, procurement, fabrication, modularization, construction, commissioning, maintenance, program management, and environmental services worldwide. The company has market cap of $1.55 billion. It operates in four divisions: Engineering & Construction, Fabrication Services, Technology, and Capital Services. It currently has negative earnings. The Engineering & Construction segment provides engineering, procurement, and construction services for energy infrastructure facilities, such as upstream and downstream process facilities for the gas and oil industry, as well as liquefied natural gas liquefaction and regasification terminals, and fossil electric generating plants for the power generation industry.

The stock increased 7.15% or $1.01 during the last trading session, reaching $15.14. About 2.79 million shares traded. Chicago Bridge & Iron Company N.V. (NYSE:CBI) has declined 47.57% since April 17, 2017 and is downtrending. It has underperformed by 59.12% the S&P500.

Since February 13, 2018, it had 3 buys, and 1 sale for $682,999 activity. $504,400 worth of stock was bought by Dockendorff Charles J on Wednesday, March 14. Nawana Namal also bought $250,023 worth of Hologic, Inc. (NASDAQ:HOLX) shares. Another trade for 5,200 shares valued at $199,826 was made by Wendell Amy McBride on Wednesday, March 14. Bebo Allison P had sold 7,000 shares worth $271,250 on Friday, March 16.

Analysts await Hologic, Inc. (NASDAQ:HOLX) to report earnings on May, 2 after the close. They expect $0.53 EPS, up 6.00% or $0.03 from last year’s $0.5 per share. HOLX’s profit will be $146.55M for 17.80 P/E if the $0.53 EPS becomes a reality. After $0.55 actual EPS reported by Hologic, Inc. for the previous quarter, Wall Street now forecasts -3.64% negative EPS growth.

Investors sentiment decreased to 0.74 in 2017 Q4. Its down 0.14, from 0.88 in 2017Q3. It is negative, as 57 investors sold HOLX shares while 165 reduced holdings. 70 funds opened positions while 94 raised stakes. 264.36 million shares or 0.45% less from 265.54 million shares in 2017Q3 were reported. Glenmede Trust Na holds 5,200 shares or 0% of its portfolio. Goldman Sachs Grp Inc Inc has invested 0.01% in Hologic, Inc. (NASDAQ:HOLX). Riverhead Capital Mngmt Limited Com stated it has 0.02% of its portfolio in Hologic, Inc. (NASDAQ:HOLX). Parallax Volatility Advisers Limited Partnership reported 6,440 shares. Strategy Asset Managers reported 57,398 shares. Rmb Mgmt Ltd Liability Corp holds 0.01% or 6,351 shares. Gemmer Asset Mgmt Ltd Liability Corporation owns 0.01% invested in Hologic, Inc. (NASDAQ:HOLX) for 557 shares. Td Asset Mngmt Inc has invested 0.05% in Hologic, Inc. (NASDAQ:HOLX). First Trust Limited Partnership reported 0.08% in Hologic, Inc. (NASDAQ:HOLX). Capital Research Global Investors holds 17.18 million shares. Strategic Advsr Ltd Liability holds 0.99% or 71,132 shares. Whittier has invested 0% in Hologic, Inc. (NASDAQ:HOLX). Sun Life Fincl has invested 0% of its portfolio in Hologic, Inc. (NASDAQ:HOLX). Virtus Investment Advisers invested 0.03% in Hologic, Inc. (NASDAQ:HOLX). North Star Asset Management has 222,423 shares for 0.85% of their portfolio.

Virtu Financial Llc increased Ziopharm Oncology Inc (NASDAQ:ZIOP) stake by 88,548 shares to 98,638 valued at $408,000 in 2017Q4. It also upped Novavax Inc (NASDAQ:NVAX) stake by 1.11 million shares and now owns 1.12M shares. Direxion Shs Etf Tr was raised too.

Hologic, Inc. (NASDAQ:HOLX) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: